Letter to FDA Urging the Agency to Seize Adulterated Ginkgo Biloba Pills
May 15, 2018
Letter to Steven Tave, Director, Office of Dietary Supplement Programs at FDA
CSPI is calling on FDA to use its enforcement authority to seize adulterated ginkgo biloba pills in the marketplace. See the original press release.